MARY CRYER: Open Payments
NPI 1912366790 · NIPOMO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $88 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $150 |
| Novo Nordisk Inc | 3 | $135 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $123 |
| Ascensia Diabetes Care Us Inc. | 2 | $111 |
| Exact Sciences Corporation | 1 | $25 |
Products named: DUPIXENT, BREZTRI, AREXVY, REZDIFFRA, SHINGRIX, The Cologuard Plus Collection Kit, Wegovy, Rybelsus.
Industry payments across CA — which companies pay providers there.
